Philips Announces First Patient Enrollment in DEFINE GPS Global Multicenter Study to Assess Superiority of PCI Procedures Guided by Co-registered iFR and Interventional Angiography

Amsterdam, the Netherlands, June 22 (Korea Bizwire) – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the official start of the DEFINE GPS study, with the first patient being enrolled by the study’s Principal Investigator, Dr. Allen Jeremias, at St. Francis Hospital, New York (U.S.). The global, multi-center, prospective, randomized controlled [...]